Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily
(QD), compared to glipizide in elderly diabetic patients who have not received treatment or
are on a single oral medication.